MenaQ7®
The only Vitamin K2 shaped strictly by data confirming true health benefits: MenaQ7®
Being able to say an ingredient is clinically validated takes an overwhelming investment and commitment, which is the exact course that has shaped the MenaQ7® Vitamin K2 as MK-7 on the market today.
Clinical studies published in peer-reviewed journals have demonstrated the efficacy of MenaQ7®, and its benefits to human health:
MenaQ7® and Cardiovascular Health
- Knapen et al. Thrombosis and Haemostasis. 2015
- Theuwissen et al. British Journal of Nutrition. 2012
- Chatrou et al. Blood Review. 2012
- Dalmeijer et al. Atherosclerosis. 2012
MenaQ7® and Bone Health
- Knapen et al. Osteoporosis International. 2013
- van Summeren et al. British Journal of Nutrition. 2009
MenaQ7® in Diseased Populations
- Kurnatowska et al. Polish Archive of Internal Medicine, 2015
- Calwue et al. Nephrology Dialysis Transplant. 2014
- Westenfeld et al. American Journal of Kidney Disease. 2012
MenaQ7® in Healthy Populations and Children’s Health
MenaQ7® for Optimal Bioavailability
This commitment to scientific research and clinical validation has earned MenaQ7® the VitaK2™ Seal of Quality and Efficacy from the world’s leading experts in vitamin K.